First Author: S.Seong SOUTH KOREA
Co Author(s): O. Kwon S. Kim Y. You H. Oh J. Lee J. Kim
Back to previous
To introduce the efficacy of vitrectomy in treating type 2 idiopathic macular telangiectasia with epiretinal membrane
Retrospective chart review of a single institution (retina centre, Nune eye Hospital)
Six eyes of six patients with type 2 idiopathic macular telangiectasia with epiretinal membrane. Main outcome measures were best-corrected visual acuity (BCVA), presence of epiretinal membrane(ERM), intraretinal cystic change, and hyperfluorescence with leakage on fluorescein angiography. Pars plana vitrectomy with membrane peeling was performed for ERM.
Six eyes with type 2 idiopathic macular telangiectasia with epiretinal membrane were treated with pars plana vitrectomy with membrane peeling. Mean follow-up was 47.5 months (range 4 months to 6 years). Mean BCVA increased from 0.22 LogMAR to 0.12 LogMAR at the end of the follow-up. All six eyes underwent vitrectomy with membrane peeling. Epiretinal membrane and intraretina cyst were disappeared successfully in all cases. Visual acuity were improved in 5 of 6 eyes and decreased in 1 eyes. 1 eye of decreased vision was just 3 months after postoperative state.
Pars plana vitrectomy in treating type 2 idiopathic macular telangiectasia with ERM has a good chance of anatomical restoration and improving vision.